e-Health and environmental sustainability in vascular surgery.


Journal

Seminars in vascular surgery
ISSN: 1558-4518
Titre abrégé: Semin Vasc Surg
Pays: United States
ID NLM: 8809602

Informations de publication

Date de publication:
Sep 2024
Historique:
received: 14 06 2024
revised: 18 08 2024
accepted: 20 08 2024
medline: 15 9 2024
pubmed: 15 9 2024
entrez: 14 9 2024
Statut: ppublish

Résumé

e-Health technology holds great promise for improving the management of patients with vascular diseases and offers a unique opportunity to mitigate the environmental impact of vascular care, which remains an under-investigated field. The innovative potential of e-Health operates in a complex environment with finite resources. As the expansion of digital health will increase demand for devices, contributing to the environmental burden of electronics and energy use, the sustainability of e-Health technology is of crucial importance, especially in the context of increasing prevalence of cardiovascular diseases. This review discusses the environmental impact of care related to vascular surgery and e-Health innovation, the potential of e-Health technology to mitigate greenhouse gas emissions generated by the health care sector, and to provide leads to research promoting e-Heath technology sustainability. A multifaceted approach, including ethical design, validated eco-audits methodology and reporting standards, technological refinement, electronic and medical devices reuse and recycling, and effective policies is required to provide a sustainable and optimal level of care to vascular patients.

Identifiants

pubmed: 39277350
pii: S0895-7967(24)00051-6
doi: 10.1053/j.semvascsurg.2024.08.005
pii:
doi:

Substances chimiques

Greenhouse Gases 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

333-341

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.

Auteurs

Gabrielle Stevenin (G)

Department of Vascular Surgery, Henri Mondor University Hospital, 1 rue Gustave Eiffel, 94000 Créteil, France; Université Paris-Est, Créteil, France.

Jennifer Canonge (J)

Department of Vascular Surgery, Henri Mondor University Hospital, 1 rue Gustave Eiffel, 94000 Créteil, France; Université Paris-Est, Créteil, France.

Marianne Gervais (M)

Université Paris-Est, Créteil, France; Institut Mondor de Recherche Biomédicale, U955 INSERM, Créteil, France.

Antonio Fiore (A)

Université Paris-Est, Créteil, France; Department of Cardiac Surgery, Henri Mondor University Hospital, Créteil, France.

Fabien Lareyre (F)

Department of Vascular Surgery, Hospital of Antibes Juan-les-Pins, France,; Université Côte d'Azur, Le Centre National de la Recherche Scientifique, UMR7370, LP2M, Nice, France; Fédération Hospitalo-Universitaire Plan&Go, Nice, France.

Joseph Touma (J)

Department of Vascular Surgery, Henri Mondor University Hospital, 1 rue Gustave Eiffel, 94000 Créteil, France; Université Paris-Est, Créteil, France.

Pascal Desgranges (P)

Department of Vascular Surgery, Henri Mondor University Hospital, 1 rue Gustave Eiffel, 94000 Créteil, France; Université Paris-Est, Créteil, France.

Juliette Raffort (J)

Université Côte d'Azur, Le Centre National de la Recherche Scientifique, UMR7370, LP2M, Nice, France; Fédération Hospitalo-Universitaire Plan&Go, Nice, France; Clinical Chemistry Laboratory, University Hospital of Nice, France; Institute 3IA Côte d'Azur, Université Côte d'Azur, France.

Jean Sénémaud (J)

Department of Vascular Surgery, Henri Mondor University Hospital, 1 rue Gustave Eiffel, 94000 Créteil, France; Université Paris-Est, Créteil, France; Laboratory for Vascular Translational Science, U1148 INSERM, Paris, France. Electronic address: jeannicolas.senemaud@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH